A citation-based method for searching scientific literature

Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hereditary ovarian cancer.
Antonio Russo, Valentina Calò, Loredana Bruno, Sergio Rizzo, Viviana Bazan, Gaetana Di Fede. Crit Rev Oncol Hematol 2009
77
100

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
335
100


Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, Cezary Cybulski, Rochelle Demsky, Susan L Neuhausen, Charmaine Kim-Sing, Nadine Tung, Susan Friedman, Leigha Senter,[...]. Int J Cancer 2015
35
100

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
434
100


Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Roger L Milne, Ana Osorio, Teresa Ramón y Cajal, Montserrat Baiget, Adriana Lasa, Eduardo Diaz-Rubio, Miguel de la Hoya, Trinidad Caldés, Alex Teulé, Conxi Lázaro,[...]. Breast Cancer Res Treat 2010
38
100

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
107
100

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
44
100

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
April D Sorrell, Carin R Espenschied, Julie O Culver, Jeffrey N Weitzel. Mol Diagn Ther 2013
56
100

Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression.
Brooke E Howitt, Kyle C Strickland, Lynette M Sholl, Scott Rodig, Lauren L Ritterhouse, Dipanjan Chowdhury, Alan D D'Andrea, Ursula A Matulonis, Panagiotis A Konstantinopoulos. Oncoimmunology 2017
47
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
100


A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
954
100

Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
Laura Cortesi, Elisabetta De Matteis, Angela Toss, Isabella Marchi, Veronica Medici, Giannina Contu, Anjeza Xholli, Giovanni Grandi, Angelo Cagnacci, Massimo Federico. Oncology 2017
15
100

Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer.
Veronica Zelli, Chiara Compagnoni, Katia Cannita, Roberta Capelli, Carlo Capalbo, Mauro Di Vito Nolfi, Edoardo Alesse, Francesca Zazzeroni, Alessandra Tessitore. High Throughput 2020
3
100

PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms.
Xuan Jiang, Xiaoying Li, Weihua Li, Huimin Bai, Zhenyu Zhang. J Cell Mol Med 2019
40
100


Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
Diane Stirling, D Gareth R Evans, Gabriella Pichert, Andrew Shenton, Elaine N Kirk, Sylvia Rimmer, C Michael Steel, Sheila Lawson, R M Camille Busby-Earle, Jane Walker,[...]. J Clin Oncol 2005
106
100

BRCA mutation in high grade epithelial ovarian cancers.
Tarinee Manchana, Natacha Phoolcharoen, Patou Tantbirojn. Gynecol Oncol Rep 2019
14
100

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
Tara M Friebel, Susan M Domchek, Timothy R Rebbeck. J Natl Cancer Inst 2014
113
100


Hereditary ovarian cancer: beyond the usual suspects.
Kathryn P Pennington, Elizabeth M Swisher. Gynecol Oncol 2012
79
100

PTEN and Gynecological Cancers.
Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, Giovanni Scambia. Cancers (Basel) 2019
8
100

Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
Angela Toss, Chiara Tomasello, Elisabetta Razzaboni, Giannina Contu, Giovanni Grandi, Angelo Cagnacci, Russell J Schilder, Laura Cortesi. Biomed Res Int 2015
75
100

Hereditary ovarian cancers: state of the art.
Angela Toss, Eleonora Molinaro, Margaret Sammarini, Maria C Del Savio, Laura Cortesi, Fabio Facchinetti, Giovanni Grandi. Minerva Med 2019
10
100

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.
Samir Gupta, Dawn Provenzale, Xavier Llor, Amy L Halverson, William Grady, Daniel C Chung, Sigurdis Haraldsdottir, Arnold J Markowitz, Thomas P Slavin, Heather Hampel,[...]. J Natl Compr Canc Netw 2019
71
100

Beyond BRCA: new hereditary breast cancer susceptibility genes.
P Economopoulou, G Dimitriadis, A Psyrri. Cancer Treat Rev 2015
90
100

The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21.
P Tonin, O Serova, J Simard, G Lenoir, J Feunteun, K Morgan, H Lynch, S Narod. Hum Mol Genet 1994
16
100

PARP Inhibitors in Epithelial Ovarian Cancer.
Kristin N Taylor, Ramez N Eskander. Recent Pat Anticancer Drug Discov 2018
26
100

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994
100


Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
Catherine A Shu, Malcolm C Pike, Anjali R Jotwani, Tara M Friebel, Robert A Soslow, Douglas A Levine, Katherine L Nathanson, Jason A Konner, Angela G Arnold, Faina Bogomolniy,[...]. JAMA Oncol 2016
109
100

HRness in Breast and Ovarian Cancers.
Elizabeth Santana Dos Santos, François Lallemand, Ambre Petitalot, Sandrine M Caputo, Etienne Rouleau. Int J Mol Sci 2020
5
100

2009 version of the Chompret criteria for Li Fraumeni syndrome.
Julie Tinat, Gaelle Bougeard, Stéphanie Baert-Desurmont, Stéphanie Vasseur, Cosette Martin, Emilie Bouvignies, Olivier Caron, Brigitte Bressac-de Paillerets, Pascaline Berthet, Catherine Dugast,[...]. J Clin Oncol 2009
198
100

BRCA and Beyond: Comprehensive Image-rich Review of Hereditary Breast and Gynecologic Cancer Syndromes.
Stephanie Histed Chung, Nina Woldenberg, Antoinette R Roth, Rinat Masamed, Wendy Conlon, Joshua G Cohen, Melissa M Joines, Maitraya K Patel. Radiographics 2020
2
100

Homologous recombination deficiency and ovarian cancer.
Jonathan A Ledermann, Yvette Drew, Rebecca S Kristeleit. Eur J Cancer 2016
89
100

Single-strand break repair and genetic disease.
Keith W Caldecott. Nat Rev Genet 2008
563
100

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
E Barrow, L Robinson, W Alduaij, A Shenton, T Clancy, F Lalloo, J Hill, D G Evans. Clin Genet 2009
193
100

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull,[...]. J Natl Cancer Inst 2020
21
100

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
M J Hall, E I Obeid, S C Schwartz, G Mantia-Smaldone, A D Forman, M B Daly. Gynecol Oncol 2016
23
100

Genetics of gynaecological cancers.
Panayiotis Constantinou, Marc Tischkowitz. Best Pract Res Clin Obstet Gynaecol 2017
9
100

Ovarian cancer screening: Current status and future directions.
Zachary Nash, Usha Menon. Best Pract Res Clin Obstet Gynaecol 2020
10
100

Current and future role of genetic screening in gynecologic malignancies.
Kari L Ring, Christine Garcia, Martha H Thomas, Susan C Modesitt. Am J Obstet Gynecol 2017
20
100

Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes.
N Jewel Samadder, Karthik V Giridhar, Noemi Baffy, Douglas Riegert-Johnson, Fergus J Couch. Mayo Clin Proc 2019
16
100

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
77
100

CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
J Szymanska-Pasternak, A Szymanska, K Medrek, E N Imyanitov, C Cybulski, B Gorski, P Magnowski, I Dziuba, K Gugala, B Debniak,[...]. Gynecol Oncol 2006
39
100

Poly(ADP-ribose) polymerase activity and inhibition in cancer.
Caleb Dulaney, Samuel Marcrom, Jennifer Stanley, Eddy S Yang. Semin Cell Dev Biol 2017
32
100


Novel therapeutics: response and resistance in ovarian cancer.
Dmitriy Zamarin. Int J Gynecol Cancer 2019
5
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.